Weekly Insulin Injections: A Breakthrough in Type 1 and Type 2 Diabetes Management
Wednesday, 11 September 2024, 02:52
New Insights into Diabetes Treatment
Recent clinical trials highlight the effectiveness of a new weekly insulin injection for managing type 1 diabetes and type 2 diabetes. Researchers have found that efsitora alfa, a new class of insulin, can control blood sugar levels comparably to traditional daily injections.
Key Findings from Clinical Trials
- In a trial involving 928 participants with type 2 diabetes, weekly efsitora maintained blood sugar as effectively as degludec.
- A second trial with 623 participants exhibiting type 1 diabetes confirmed similar outcomes between weekly efsitora and daily degludec.
Citing Dr. Carol Wysham, the trials suggest that weekly injections could reduce patient burden associated with daily insulin therapy, making management of diabetes more accessible for many.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.